bis(molybdopterin)tungsten cofactor
Star0
Identification
- Generic Name
- bis(molybdopterin)tungsten cofactor
- DrugBank Accession Number
- DB01794
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 990.77
Monoisotopic: 989.899095 - Chemical Formula
- C20H20MgN10O12P2S4W
- Synonyms
- Tungstopterin
- W-molybdopterin cofactor
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as molybdopterins. These are cofactors or analogs thereof, with a structure based on a furan ring fused to a pterin. In addition, the pyran ring features two thiolates, which serve as ligands in molybdo- and tungstoenzymes. In some cases, the alkyl phosphate group is replaced by an alkyl diphosphate nucleotide.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Pteridines and derivatives
- Sub Class
- Pterins and derivatives
- Direct Parent
- Molybdopterins
- Alternative Parents
- Pyranopterins and derivatives / Secondary alkylarylamines / Pyrimidones / Aminopyrimidines and derivatives / Pyrans / Imidolactams / Organic phosphoric acids and derivatives / Vinylogous amides / Heteroaromatic compounds / Lactams show 10 more
- Substituents
- Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Heteroaromatic compound / Hydrocarbon derivative / Imidolactam / Lactam / Metalloheterocycle / Molybdopterin show 20 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- W-molybdopterin cofactor (CHEBI:30402)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- TXTOFHXWJBZWPO-UHFFFAOYSA-F
- InChI
- InChI=1S/2C10H14N5O6PS2.Mg.W/c2*11-10-14-7-4(8(16)15-10)12-3-6(24)5(23)2(21-9(3)13-7)1-20-22(17,18)19;;/h2*2-3,9,12,23-24H,1H2,(H2,17,18,19)(H4,11,13,14,15,16);;/q;;+2;+4/p-8
- IUPAC Name
- 10,32-diamino-8,19,23,34-tetraoxo-15,18,20,22,24,27-hexaoxa-2,40,41,42-tetrathia-6,9,11,13,29,31,33,36-octaaza-19lambda5,23lambda5-diphospha-1-tungsta-21-magnesanonacyclo[36.2.1.1^{1,4}.0^{3,16}.0^{5,14}.0^{7,12}.0^{26,39}.0^{28,37}.0^{30,35}]dotetraconta-3,7(12),10,30(35),31,38-hexaene-19,23-bis(olate)
- SMILES
- NC1=NC2=C(NC3C(N2)OC2COP([O-])(=O)O[Mg]OP([O-])(=O)OCC4OC5NC6=C(NC5C5=C4S[W]4(SC2=C3S4)S5)C(=O)NC(N)=N6)C(=O)N1
References
- General References
- Not Available
- External Links
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 15.2 mg/mL ALOGPS logP 0.3 ALOGPS logP -1 Chemaxon logS -1.8 ALOGPS pKa (Strongest Acidic) 3.94 Chemaxon pKa (Strongest Basic) 1.25 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 16 Chemaxon Hydrogen Donor Count 8 Chemaxon Polar Surface Area 318.72 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 189.66 m3·mol-1 Chemaxon Polarizability 71.12 Å3 Chemaxon Number of Rings 9 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption - 0.9812 Blood Brain Barrier + 0.5879 Caco-2 permeable - 0.622 P-glycoprotein substrate Substrate 0.5667 P-glycoprotein inhibitor I Non-inhibitor 0.7252 P-glycoprotein inhibitor II Non-inhibitor 0.9772 Renal organic cation transporter Non-inhibitor 0.9118 CYP450 2C9 substrate Non-substrate 0.8079 CYP450 2D6 substrate Non-substrate 0.8075 CYP450 3A4 substrate Non-substrate 0.5098 CYP450 1A2 substrate Non-inhibitor 0.6665 CYP450 2C9 inhibitor Non-inhibitor 0.6809 CYP450 2D6 inhibitor Non-inhibitor 0.8617 CYP450 2C19 inhibitor Non-inhibitor 0.6368 CYP450 3A4 inhibitor Non-inhibitor 0.7211 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.6935 Ames test Non AMES toxic 0.5861 Carcinogenicity Non-carcinogens 0.885 Biodegradation Not ready biodegradable 0.9775 Rat acute toxicity 2.6088 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9725 hERG inhibition (predictor II) Non-inhibitor 0.5616
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52